JP2025098147A5 - - Google Patents
Info
- Publication number
- JP2025098147A5 JP2025098147A5 JP2025049941A JP2025049941A JP2025098147A5 JP 2025098147 A5 JP2025098147 A5 JP 2025098147A5 JP 2025049941 A JP2025049941 A JP 2025049941A JP 2025049941 A JP2025049941 A JP 2025049941A JP 2025098147 A5 JP2025098147 A5 JP 2025098147A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- fat
- ligand
- composition according
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL264112A IL264112A (en) | 2019-01-06 | 2019-01-06 | An a3 adenosine receptor ligand for use for reducing level of adipocytes |
| IL264112 | 2019-01-06 | ||
| JP2021539140A JP2022517753A (ja) | 2019-01-06 | 2020-01-05 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
| JP2023078136A JP2023100928A (ja) | 2019-01-06 | 2023-05-10 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023078136A Division JP2023100928A (ja) | 2019-01-06 | 2023-05-10 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025098147A JP2025098147A (ja) | 2025-07-01 |
| JP2025098147A5 true JP2025098147A5 (https=) | 2026-04-06 |
Family
ID=65656120
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539140A Pending JP2022517753A (ja) | 2019-01-06 | 2020-01-05 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
| JP2023078136A Pending JP2023100928A (ja) | 2019-01-06 | 2023-05-10 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
| JP2025049941A Pending JP2025098147A (ja) | 2019-01-06 | 2025-03-25 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539140A Pending JP2022517753A (ja) | 2019-01-06 | 2020-01-05 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
| JP2023078136A Pending JP2023100928A (ja) | 2019-01-06 | 2023-05-10 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12213990B2 (https=) |
| EP (1) | EP3906034A1 (https=) |
| JP (3) | JP2022517753A (https=) |
| KR (1) | KR20210113279A (https=) |
| CN (1) | CN113543790A (https=) |
| AU (1) | AU2020205042B2 (https=) |
| BR (1) | BR112021013084A2 (https=) |
| CA (1) | CA3126002A1 (https=) |
| IL (2) | IL264112A (https=) |
| MX (1) | MX2021008172A (https=) |
| WO (1) | WO2020141535A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202300014340A1 (it) * | 2023-07-10 | 2025-01-10 | Consiglio Nazionale Ricerche | Trattamento di malattie associate alla disfunzione del gene ocrl. |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5443836A (en) | 1993-03-15 | 1995-08-22 | Gensia, Inc. | Methods for protecting tissues and organs from ischemic damage |
| WO1995002604A1 (en) | 1993-07-13 | 1995-01-26 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | A3 adenosine receptor agonists |
| US5688774A (en) | 1993-07-13 | 1997-11-18 | The United States Of America As Represented By The Department Of Health And Human Services | A3 adenosine receptor agonists |
| WO1997027173A2 (en) | 1996-01-24 | 1997-07-31 | Sumitomo Chemical Company, Limited | Dihalopropene compounds, their use as insecticides/acaricides and intermediates for their production |
| US6048865A (en) | 1997-07-29 | 2000-04-11 | Medco Research, Inc. | N6 -substituted-adenosine-5'-uronamides as adenosine receptor modulator |
| JP2003517423A (ja) | 1997-07-29 | 2003-05-27 | メドコ リサーチ、インコーポレイテッド | アデノシンレセプターモジュレーターとしてのｎ６−置換アデノシン−５′−ウロナミド |
| AU1363699A (en) | 1997-10-23 | 1999-05-10 | National Institute Of Health | Methods for reducing ischemic injury of the heart via the sequential administ ration of monophosphoryl lipid a and adenosine receptor agents |
| IL133680A0 (en) | 1999-09-10 | 2001-04-30 | Can Fite Technologies Ltd | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| US6946449B2 (en) | 2001-07-13 | 2005-09-20 | Cv Therapeutics, Inc. | Partial and full agonists of A1 adenosine receptors |
| EP1983990B1 (en) | 2006-01-26 | 2011-03-23 | Government of the United States of America, Represented by the Secretary, Department of Health and Human Services | A3 adenosine receptor allosteric modulators |
| US20130324461A1 (en) * | 2010-08-26 | 2013-12-05 | Michail V. Sitkovsky | Methods and compositions for preventing or treating obesity |
| JP2015504088A (ja) | 2012-01-23 | 2015-02-05 | キャン−ファイト バイオファーマ リミテッドＣａｎ−Ｆｉｔｅ ＢｉｏＰｈａｒｍａ Ｌｔｄ． | 肝疾患の治療 |
| IL242723B (en) | 2015-11-23 | 2019-12-31 | Can Fite Biopharma Ltd | A3 adenosine receptor ligand for the treatment of ectopic fat accumulation |
| KR101881441B1 (ko) * | 2017-01-20 | 2018-07-24 | 서울대학교산학협력단 | 다중 약리단 특성에 기반한 비정상적 아디포넥틴 관련 질환 치료용 조성물 |
-
2019
- 2019-01-06 IL IL264112A patent/IL264112A/en unknown
-
2020
- 2020-01-05 WO PCT/IL2020/050011 patent/WO2020141535A1/en not_active Ceased
- 2020-01-05 CN CN202080008167.6A patent/CN113543790A/zh active Pending
- 2020-01-05 MX MX2021008172A patent/MX2021008172A/es unknown
- 2020-01-05 BR BR112021013084-5A patent/BR112021013084A2/pt unknown
- 2020-01-05 CA CA3126002A patent/CA3126002A1/en active Pending
- 2020-01-05 IL IL284463A patent/IL284463B1/en unknown
- 2020-01-05 JP JP2021539140A patent/JP2022517753A/ja active Pending
- 2020-01-05 US US17/309,952 patent/US12213990B2/en active Active
- 2020-01-05 KR KR1020217024682A patent/KR20210113279A/ko active Pending
- 2020-01-05 AU AU2020205042A patent/AU2020205042B2/en active Active
- 2020-01-05 EP EP20700855.8A patent/EP3906034A1/en active Pending
-
2023
- 2023-05-10 JP JP2023078136A patent/JP2023100928A/ja active Pending
-
2025
- 2025-03-25 JP JP2025049941A patent/JP2025098147A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7650929B2 (ja) | 成人における焦点てんかんの処置のための合成経皮的カンナビジオール | |
| JP2021066744A5 (ja) | ブプロピオンおよびデキストロメトルファンを含む組成物 | |
| JP2023041862A5 (https=) | ||
| JP2020073566A5 (https=) | ||
| JP2007512371A5 (https=) | ||
| JP2017533972A5 (https=) | ||
| JP2025098147A5 (https=) | ||
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| JP2013516493A5 (https=) | ||
| JP2006514092A5 (https=) | ||
| JP2024500324A5 (https=) | ||
| JP2020522560A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| JP2023549849A5 (https=) | ||
| JP2012525358A5 (https=) | ||
| JP2019507786A5 (https=) | ||
| RU2016137926A (ru) | Композиции грапипранта и способы их применения | |
| JP2013543897A5 (https=) | ||
| JP2023531930A5 (https=) | ||
| JP2019535830A5 (https=) | ||
| JP2006508994A5 (https=) | ||
| JP2003055205A (ja) | 抗真菌病組成物 | |
| RU2009145804A (ru) | Аксомадол для лечения боли от артроза | |
| JP2007512381A5 (https=) | ||
| CN112007006B (zh) | 一种治疗口腔溃疡的药用组合物及其制备方法 |